Omalizumab Subcutaneous and Orencia
Determining the interaction of Omalizumab Subcutaneous and Orencia and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: abatacept
Brand name: Orencia, Orencia ClickJect, Orencia Prefilled Syringe
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Orencia (Abatacept Auto-Injectors)
- Omalizumab Subcutaneous-Orencia (Abatacept Infusion)
- Omalizumab Subcutaneous-Orencia (Abatacept Prefilled Syringes)
- Omalizumab Subcutaneous-Orenitram
- Omalizumab Subcutaneous-Orfadin
- Omalizumab Subcutaneous-Orfadin (Nitisinone Capsules)
- Orencia-Ombitasvir, Paritaprevir, and Ritonavir
- Orencia-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Orencia-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Orencia-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Orencia-Omeclamox-Pak
- Orencia-Omega-3 Fatty Acid Capsules